 MINNEAPOLIS, MN ACCESSWIRE October 29, 2021 Celcuity Inc. NASDAQ:CELC, a clinical-stage biotechnology company pursuing an integrated companion diagnostic and therapeutic strategy for treating patients with cancer, today announced that it will release its financial results for the third quarter 2021 after the stock market close on Monday, November 8, 2021. Management will host a webcastteleconference the same day at 4:30 p.m. 